# Pirfenidone as Treatment of Chronic Pancreatitis

> **NCT07755813** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Vikas Dudeja** · enrollment: 60 (estimated)

## Conditions studied

- Chronic Pancreatitis

## Interventions

- **DRUG:** Pirfenidone 267 mg Oral Tablet
- **DRUG:** Placebo
- **OTHER:** PROMIS-Global Health
- **OTHER:** Comprehensive Pain Assessment Tool
- **OTHER:** Brief Pain Inventory
- **OTHER:** Pancreatitis Quality of Life Instrument

## Key facts

- **NCT ID:** NCT07755813
- **Lead sponsor:** Vikas Dudeja
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2030-08
- **Final completion:** 2030-08
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-08-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07755813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07755813, "Pirfenidone as Treatment of Chronic Pancreatitis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07755813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*